🔗 Permalink

Inventor profile of:

Michael J Hope

City:

Vancouver

Country:

Canada

Published Applications:

Last publication date:

2026-04-02

Top Assignees for applications by Michael J Hope

The entities that hold a legal rights for patent applications filed by inventor Hope Michael J:

The University of British Columbia 8 Vancouver, Canada
TEKMIRA PHARMACEUTICALS CORPORATION 5 Burnaby, BC Canada
Acuitas Therapeutics, Inc. 5 Vancouver, Canada
Tekmira Pharmaceuticals Corporation 4 Burnaby, Canada
The University of British Columbia 4 Vancouver, BC Canada
ALNYLAM PHARMACEUTICALS, INC. 3 Cambridge, MA United States
CureVac SE 2 Tübingen, Germany
Inex Pharmaceuticals Corporation 2 Burnaby, Canada
Acuitas Therapeutics Inc. 1 Vancouver, BC Canada
CureVac AG 1 Tübingen, Germany
THE UNIVERSITY OF BRITISH COLUMBIA 1 Vancouver, British Columbia, Canada
Alnylam Pharmaceuticals 1 Cambridge, MA United States
ARBUTUS BIOPHARMA CORPORATION 1 Burnaby, British Columbia, Canada
ARBUTUS BIOPHARMA CORPORATION 1 Burnaby, Canada
ARBUTUS BIOPHARMA CORPORATION 1 Warminster, PA United States

Recent patent applications by Hope Michael J

Michael J Hope from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-02

US20260090989A1

Human necessities

LIPID NANOPARTICLE mRNA VACCINES

#2 | 2025-09-18

US20250288522A1

Human necessities

LIPID NANOPARTICLE mRNA VACCINES

#3 | 2023-11-23

US20230372537A1

Human necessities

LIPID NANOPARTICLE FORMULATIONS

#4 | 2022-03-10

US20220074925A1

Physics

SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS

#5 | 2022-02-10

US20220040285A1

Human necessities

Nucleoside-Modified RNA For Inducing an Adaptive Immune Response

#6 | 2021-08-19

US20210251898A1

Human necessities

LIPID NANOPARTICLE MRNA VACCINES

#7 | 2020-07-16

US20200225215A1

Physics

SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS

#8 | 2020-05-28

US20200163878A1

Human necessities

LIPID NANOPARTICLE MRNA VACCINES

#9 | 2020-04-23

US20200121809A1

Human necessities

Lipid nanoparticle formulations

#10 | 2019-09-12

US20190274968A1

Human necessities

NUCLEOSIDE-MODIFIED RNA FOR INDUCING AN ADAPTIVE IMMUNE RESPONSE

#11 | 2018-10-25

US20180303925A1

Human necessities

Nucleoside-Modified RNA For Inducing an Adaptive Immune Response

#12 | 2018-07-26

US20180209963A1

Physics

SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS

#13 | 2018-07-05

US20180185516A1

Human necessities

DELIVERY OF TARGET SPECIFIC NUCLEASES

#14 | 2016-11-03

US20160317676A1

Human necessities

METHODS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS

#15 | 2016-09-22

US20160274089A1

Physics

SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS

#16 | 2016-04-07

US20160095924A1

Human necessities

Amino lipids and methods for the delivery of nucleic acids

#17 | 2013-01-17

US20130017223A1

Human necessities

METHODS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS

#18 | 2012-09-06

US20120225434A1

Physics

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

#19 | 2012-05-10

US20120114831A1

Human necessities

HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES

#20 | 2011-10-20

US20110256175A1

Human necessities

Amino lipids and methods for the delivery of nucleic acids

#21 | 2011-05-19

US20110117125A1

Human necessities

COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS

#22 | 2011-04-28

US20110097720A1

Physics

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

#23 | 2010-02-18

US20100041152A1

Chemistry; metallurgy

METHODS FOR ENCAPSULATING PLASMIDS IN LIPID BILAYERS

#24 | 2009-11-19

US20090285878A1

Human necessities

Compositions and methods for stabilizing liposomal drug formulations

#25 | 2008-08-21

US20080200417A1

Human necessities

Lipid-encapsulated polyanionic nucleic acid

#26 | 2006-09-05

US9992107

Liposome compositions and methods for the treatment of atherosclerosis

#27 | 2006-01-12

US20060008909A1

Human necessities

Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

#28 | 2005-11-17

US20050255153A1

Human necessities

Lipid-encapsulated polyanionic nucleic acid

#29 | 2005-11-10

US20050249794A1

Human necessities

Compositions for stimulating cytokine secretion and inducing an immune response

#30 | 2005-02-22

US9895480

Lipid-encapsulated polyanionic nucleic acid

#31 | 2005-01-13

US20050008689A1

Human necessities

High efficiency encapsulation of charged therapeutic agents in lipid vesicles

InventorID:

40282 ⎘